113 related articles for article (PubMed ID: 3444905)
1. Phase II double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung.
Privitera G; Ciottoli GB; Patanè C; Palmucci T; Tafuri G; Marletta F; De Luca B; Magnani F; De Gregorio M; Greco S
Radiother Oncol; 1987 Dec; 10(4):285-90. PubMed ID: 3444905
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized comparison of radiation therapy plus lonidamine versus radiation therapy plus placebo as initial treatment of clinically localized but nonresectable nonsmall cell lung cancer.
Scarantino CW; McCunniff AJ; Evans G; Young CW; Paggiarino DA
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):999-1004. PubMed ID: 8083102
[TBL] [Abstract][Full Text] [Related]
3. Double-blind randomized study of lonidamine and radiotherapy in head and neck cancer.
Magno L; Terraneo F; Bertoni F; Tordiglione M; Bardelli D; Rosignoli MT; Ciottoli GB
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):45-55. PubMed ID: 8175445
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of lonidamine in non-small cell lung cancer: final report.
Kokron O; Maca S; De Gregorio M; Ciottoli GB
Br J Cancer; 1990 Feb; 61(2):316-8. PubMed ID: 2155644
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of lonidamine in inoperable non-small-cell lung cancer.
Kokron O; Maca S; Scheiner W; De Gregorio M; Ciottoli GB
Oncology; 1984; 41 Suppl 1():86-9. PubMed ID: 6717902
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancer.
Filipazzi V; Cattaneo MT; Rho B; Frontini L; D'Adda D; Isa L; Scapaticci R; Legnani W; Calzavara MP; Berni F
Oncology; 1993; 50(1):10-3. PubMed ID: 8380632
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancer.
Buccheri G; Ferrigno D; Rosso A
Cancer; 1993 Sep; 72(5):1564-72. PubMed ID: 8394198
[TBL] [Abstract][Full Text] [Related]
8. Chronic administration of lonidamine in untreated non-small cell lung cancer of stage III M0-1.
Scagliotti GV; Gozzelino F; Albera C; Pescetti G
Chemotherapy; 1989; 35(1):64-8. PubMed ID: 2541978
[TBL] [Abstract][Full Text] [Related]
9. The combined use of radiation therapy and lonidamine in the treatment of brain metastases.
DeAngelis LM; Currie VE; Kim JH; Krol G; O'Hehir MA; Farag FM; Young CW; Posner JB
J Neurooncol; 1989 Sep; 7(3):241-7. PubMed ID: 2677257
[TBL] [Abstract][Full Text] [Related]
10. Lonidamine alone and in combination with other chemotherapeutic agents in the treatment of cancer patients.
Pacilio G; Carteni G; Biglietto M; De Cesare M
Oncology; 1984; 41 Suppl 1():108-12. PubMed ID: 6326014
[TBL] [Abstract][Full Text] [Related]
11. A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancer. Cuneo Lung Cancer Study Group (CuLCaSG).
Buccheri G; Ferrigno D
Eur J Cancer; 1994; 30A(10):1424-31. PubMed ID: 7833096
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy plus lonidamine in non-small cell lung cancer.
Cionini L
Semin Oncol; 1991 Apr; 18(2 Suppl 4):49-52. PubMed ID: 1851578
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of lonidamine in patients with small cell carcinoma of the lung.
Murray N; Shah A; Band P
Cancer Treat Rep; 1987 Dec; 71(12):1283-4. PubMed ID: 2825992
[TBL] [Abstract][Full Text] [Related]
14. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
[TBL] [Abstract][Full Text] [Related]
15. Phase III trial with and without lonidamine in non-small cell lung cancer.
Gatzemeier U; Cavalli F; Häussinger K; Kaukel E; Koschel G; Martinelli G; Neuhauss R; von Pawel J
Semin Oncol; 1991 Apr; 18(2 Suppl 4):42-8. PubMed ID: 1851577
[TBL] [Abstract][Full Text] [Related]
16. [Double blind controlled study of ubenimex (Bestatin) against squamous cell lung cancer--a multicenter cooperative study].
Furuse K; Fukuoka M; Genka K; Kato H; Tsubura E; Ohta M; Nakai H; Kinuwaki E; Nakano M; Ishikawa S
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1187-94. PubMed ID: 8333747
[TBL] [Abstract][Full Text] [Related]
17. Lonidamine in the combined treatment of malignant gliomas. A randomized study.
Carapella CM; Paggi MG; Calvosa F; Cattani F; Jandolo B; Mastrostefano R; Raus L; Riccio A
J Neurosurg Sci; 1990; 34(3-4):261-4. PubMed ID: 2098504
[TBL] [Abstract][Full Text] [Related]
18. Thoracic irradiation with or without levamisole (NSC #177023) in unresectable non-small cell carcinoma of the lung: a phase III randomized trial of the RTOG.
Perez CA; Bauer M; Emami BN; Byhardt R; Brady LW; Doggett RL; Gardner P; Zinninger M
Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1337-46. PubMed ID: 2848786
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trial.
Ianniello GP; De Cataldis G; Comella P; Scarpati MD; Maiorino A; Brancaccio L; Cioffi R; Lombardi A; Carnicelli P; Tinessa V
Cancer; 1996 Jul; 78(1):63-9. PubMed ID: 8646728
[TBL] [Abstract][Full Text] [Related]
20. Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck.
Colella E; Merlano M; Blengio F; Angelini F; Ausili Cefaro GP; Scasso F; Lo Russo V; Cirulli S; Giannarelli D; Cognetti F
Eur J Cancer; 1994; 30A(7):928-30. PubMed ID: 7946585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
